title: Central and peripheral haemodynamic responses to felodipine in congestive heart failure.
abstract: Using non-invasive radionuclide techniques, we studied the arterial and venous effects of 0.1 mg/kg oral felodipine in 12 men with heart failure due to ischaemic heart disease aged 37-72 y. All were in New York Heart Association Class II or III, required frusemide 40-120 mg daily and were clinically stable. Felodipine produced significant falls in blood pressure (-19%) and systemic vascular resistance (-39%) with increases in cardiac index (+34%), heart rate (+12%) and left ventricular ejection fraction (from 0.25 to 0.32). Peripheral venous volume fell by 10.6% after felodipine indicating venoconstriction rather than venodilatation and may be caused by an acute sympathetic reflex associated with the increase in heart rate. Our results confirm that felodipine is an arterial vasodilator. The previously observed changes in cardiac filling pressures may simply represent improved ventricular function as a consequence of reduced afterload, not venodilatation.
authors.affiliation: Department of Medicine, Royal Infirmary, Edinburgh, UK.
authors.forename: S
authors.initials: S
authors.lastname: Capewell
authors.forename: C G
authors.initials: CG
authors.lastname: Wathen
authors.forename: A L
authors.initials: AL
authors.lastname: Muir
mesh_terms: D000328:Adult; D000368:Aged; D003187:Compliance / Q000187:drug effects; D015736:Felodipine / Q000009:adverse effects / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: D015736:Felodipine